Tuesday, 31 March 2015

New cancer drugs 'vastly overestimated', says contrarian analyst

LONDON (Reuters) - A hot new class of drugs designed to help the body's own immune system fend off cancer by blocking a protein called PD-1 is going to be big - but not nearly as big as investors think, according to a new analysis.


via Reuters: Health News Read More Here..

No comments:

Post a Comment